This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lucerne, CH (2014 - 2016)
- Hoboken, NJ (US) (2022 - 2023)
Company Filing History:
Years Active: 2014-2023
Title: The Innovative Contributions of Eric Sirota
Introduction
Eric Sirota is a notable inventor based in Hoboken, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel solid forms of ceftolozane and BACE inhibitors. With a total of 4 patents to his name, Sirota's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Sirota's latest patents is focused on solid forms of ceftolozane and processes for preparing them. This invention relates to a novel solid form of ceftolozane sulfate, specifically the DMAc solvate of ceftolozane sulfate (Form 3). The patent includes compositions comprising ceftolozane sulfate DMAc solvate (Form 3), the synthesis of Form 3, and an improved crystallization process to prepare ceftolozane sulfate Form 2. Additionally, it covers novel compositions that include ceftolozane sulfate solid Form 3 and other crystalline and amorphous solid forms of ceftolozane.
Another significant patent by Sirota involves a crystalline form of a BACE inhibitor, specifically Crystalline Form II of Verubecestat. This invention provides pharmaceutically acceptable compositions that may be useful in treating, preventing, ameliorating, and delaying the onset of Aβ pathologies, including Alzheimer's disease and mild cognitive impairment.
Career Highlights
Eric Sirota is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that can lead to better therapeutic outcomes for patients.
Collaborations
Sirota has collaborated with several professionals in his field, including Rositza Petrova and Robert Wenslow. These collaborations have likely contributed to the success of his innovative projects and patents.
Conclusion
Eric Sirota's contributions to the field of pharmaceuticals through his patents and innovative work at Merck Sharp & Dohme Corporation highlight his role as a significant inventor. His research and developments have the potential to make a meaningful impact on the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile